David Sidransky

671 total citations
11 papers, 512 citations indexed

About

David Sidransky is a scholar working on Molecular Biology, Otorhinolaryngology and Oncology. According to data from OpenAlex, David Sidransky has authored 11 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Otorhinolaryngology and 5 papers in Oncology. Recurrent topics in David Sidransky's work include Head and Neck Cancer Studies (5 papers), Cancer-related Molecular Pathways (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). David Sidransky is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Cancer-related Molecular Pathways (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). David Sidransky collaborates with scholars based in United States, Germany and Japan. David Sidransky's co-authors include Monica Hollstein, Atul Bedi, Michael I. Collector, Saul J. Sharkis, Ephraim J. Fuchs, Mark Schoenberg, Rajani Ravi, Mack Mabry, Gauri C. Bedi and Richard J. Jones and has published in prestigious journals such as Nature Medicine, Blood and International Journal of Cancer.

In The Last Decade

David Sidransky

10 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Sidransky United States	6	317	271	94	84	78	11	512
Jean‐Charles Ahomadegbe France	13	392 1.2×	340 1.3×	97 1.0×	59 0.7×	26 0.3×	18	597
Tetsuyo ODAJIMA Japan	12	272 0.9×	178 0.7×	66 0.7×	67 0.8×	27 0.3×	32	471
Öonagh Loughran United Kingdom	7	308 1.0×	251 0.9×	89 0.9×	23 0.3×	40 0.5×	8	464
Yuuji Nakahara Japan	12	355 1.1×	278 1.0×	94 1.0×	50 0.6×	16 0.2×	14	534
Amol N.S. Rakkar United States	7	269 0.8×	298 1.1×	76 0.8×	75 0.9×	37 0.5×	9	484
P. J. Slootweg Netherlands	6	192 0.6×	193 0.7×	74 0.8×	36 0.4×	16 0.2×	7	324
N G Kastrinakis Greece	7	178 0.6×	98 0.4×	57 0.6×	51 0.6×	30 0.4×	7	354
D.N. Dokianakis Greece	10	230 0.7×	303 1.1×	89 0.9×	84 1.0×	9 0.1×	12	468
Motoko Seto Japan	12	420 1.3×	223 0.8×	86 0.9×	96 1.1×	38 0.5×	17	603
Andy Goberdhan United States	5	346 1.1×	202 0.7×	111 1.2×	44 0.5×	18 0.2×	7	535

Countries citing papers authored by David Sidransky

Since Specialization

Citations

This map shows the geographic impact of David Sidransky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sidransky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sidransky more than expected).

Fields of papers citing papers by David Sidransky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sidransky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sidransky. The network helps show where David Sidransky may publish in the future.

Co-authorship network of co-authors of David Sidransky

This figure shows the co-authorship network connecting the top 25 collaborators of David Sidransky. A scholar is included among the top collaborators of David Sidransky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sidransky. David Sidransky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Zinzani, Pier Luigi, Eric D. Jacobsen, Jasmine Zain, et al.. (2024). Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Final Results from the Phase 2 PRIMO Trial. Blood. 144(Supplement 1). 3061–3061. 4 indexed citations

Docimo, Steven G., Nan‐Haw Chow, Gabriel Steiner, et al.. (1999). Detection of adenocarcinoma by urinary microsatellite analysis after augmentation cystoplasty. Urology. 54(3). 561–561. 17 indexed citations

Yamaguchi, Kengo, et al.. (1999). Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines. Cancer Letters. 139(2). 183–187. 57 indexed citations

Reed, Abby, et al.. (1997). Temporal Inactivation of pl6 (CDKN2, INK4A, NITS‐1) Tumor Suppressor Gene: Is p16 the Gatekeeper Gene of Head and Neck Squamous Cell Carcinoma?. Otolaryngology. 117(2). P79–P79. 1 indexed citations

Linn, Jürgen F., et al.. (1997). Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. International Journal of Cancer. 74(6). 625–629. 48 indexed citations

Sewell, D L, et al.. (1997). Loss of Heterozygosity on 13q is Associated with Decreased Survival Rates in Head and Neck Cancer Patients. Otolaryngology. 117(2). P128–P128.

Sidransky, David, et al.. (1997). Lack of BRCA2 Alterations in Primary Head and Neck Squamous Cell Carcinoma. Otolaryngology. 117(2). P127–P128. 2 indexed citations

Sidransky, David, et al.. (1997). Identification of the Site of Origin of Unknown Primary Squamous Cell Carcinoma of the Head and Neck Using Microsatellite Analysis. Otolaryngology. 117(2). P130–P130. 2 indexed citations

Akhtar, Adil, Gauri C. Bedi, David Sidransky, et al.. (1996). Selective radiosensitization of p53–deficient cells by caffeine–mediated activation of p34cdc2 kinase. Nature Medicine. 2(10). 1140–1143. 139 indexed citations

10.

Sidransky, David & Monica Hollstein. (1996). CLINICAL IMPLICATIONS OF THE p53 GENE. Annual Review of Medicine. 47(1). 285–301. 153 indexed citations

11.

Sidransky, David. (1995). Molecular genetics of head and neck cancer. Current Opinion in Oncology. 7(3). 229–233. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact